BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3274806)

  • 21. Graft-versus-host-induced immunosuppression. The effect of antigenic stimulation on cell-mediated and humoral immune responses.
    Treiber W; Lapp WS
    Transplantation; 1973 Sep; 16(3):211-6. PubMed ID: 4147031
    [No Abstract]   [Full Text] [Related]  

  • 22. Tolerance induction using autologous bone marrow modified with an allogeneic class I MHC gene.
    Sachs DH; Bodine DM; Moulton AD; Pearson DA; Nienhuis AW; Sykes M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):348-9. PubMed ID: 8438329
    [No Abstract]   [Full Text] [Related]  

  • 23. Tolerance induction in concordant heart-xenografted mice by CD4 and CD8 monoclonal antibodies.
    Chen Z; Cobbold SP; Waldmann H; Metcalfe SM
    Transplant Proc; 1994 Jun; 26(3):1199-200. PubMed ID: 8029885
    [No Abstract]   [Full Text] [Related]  

  • 24. Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation.
    Matsuura T; Imanishi M; Hara Y; Tahara H; Kanda H; Kurita T
    Transplant Proc; 1994 Aug; 26(4):1962-3. PubMed ID: 7520616
    [No Abstract]   [Full Text] [Related]  

  • 25. F1 hybrid resistance and self-tolerance in graft-versus-host mice.
    Baron C; Bierre V; Weil B; Lang P
    Transplant Proc; 1996 Oct; 28(5):2921-2. PubMed ID: 8908125
    [No Abstract]   [Full Text] [Related]  

  • 26. An allogeneic immunosuppressive monoclonal anti-T cell antibody can elicit neutralizing anti-antibodies in mice.
    Kremmer E; Mysliwietz J; Lederer R; Thierfelder S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):842-3. PubMed ID: 8094918
    [No Abstract]   [Full Text] [Related]  

  • 27. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolerance induction to islet allografts following infusion of perforin deficient bone marrow.
    Selvaggi G; Inverardi L; Levy RB; Mintz DH; Podack ER; Ricordi C
    Transplant Proc; 1995 Dec; 27(6):3193. PubMed ID: 8539907
    [No Abstract]   [Full Text] [Related]  

  • 29. Bone marrow transplantation across major histocompatability barriers in mice. III. Treatment of donor grafts with monoclonal antibodies directed against Lyt determinants.
    Vallera DA; Soderling CC; Kersey JH
    J Immunol; 1982 Feb; 128(2):871-5. PubMed ID: 6172513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-tolerance restoration of irradiated graft-versus-host mice after thymus grafting.
    Baron C; Bierre V; Weil B; Lang P
    Transplant Proc; 1995 Aug; 27(4):2486-7. PubMed ID: 7652898
    [No Abstract]   [Full Text] [Related]  

  • 31. Linked suppression of skin graft rejection can operate through indirect recognition.
    Wise MP; Bemelman F; Cobbold SP; Waldmann H
    J Immunol; 1998 Dec; 161(11):5813-6. PubMed ID: 9834057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
    Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of donor-specific tolerance in sublethally irradiated recipients by gene therapy.
    Forman D; Tian C; Iacomini J
    Mol Ther; 2005 Aug; 12(2):353-9. PubMed ID: 15939670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppression using a monoclonal antibody to ICAM-1 in murine allotransplantation.
    Guymer RH; Mandel TE
    Transplant Proc; 1992 Feb; 24(1):218-9. PubMed ID: 1347183
    [No Abstract]   [Full Text] [Related]  

  • 35. Composite vascularized skin/bone transplantation models for bone marrow-based tolerance studies.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Siemionow M
    Ann Plast Surg; 2006 Mar; 56(3):295-300. PubMed ID: 16508361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic marrow transplants in cyclophosphamide treated mice.
    Santos GW; Owens AH
    Transplant Proc; 1969 Mar; 1(1):44-6. PubMed ID: 4400067
    [No Abstract]   [Full Text] [Related]  

  • 37. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of monoclonal antibodies for the prevention of graft-versus-host and host-versus-graft reaction in allogenic bone marrow grafts].
    Hervé P
    Nephrologie; 1987; 8(3):103-8. PubMed ID: 3309699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction and suppression of anti-antibodies to syngeneic T cell-binding antibodies in mice.
    Kremmer E; Mysliwietz J; Thierfelder S
    Clin Exp Immunol; 1997 Jul; 109(1):180-4. PubMed ID: 9218842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rejection/acceptance of xenografts.
    Sakakibara N; Click RE; Condie RM; Jamieson SW
    Transplant Proc; 1989 Feb; 21(1 Pt 1):524-6. PubMed ID: 2650191
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.